# K080509: Cardioblate 68000 Gnerator, BP2 Surgical Ablation Device, LP Surgical Ablation Device, Gemini-Ssurgical Ablation Device

- Pathway: 510(k) (Traditional)
- Applicant: Medtronic, Inc.
- Decided: May 5, 2008 after 70 days
- Product code: OCL (Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue)
- Device class: 2
- Regulation: 21 CFR 878.4400
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K942299 (1995). 54 ancestors in all.
10 later devices descend from it; 5 cite it directly.
0 of 65 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K013392: Cardioblate Surgical Ablation Pen, Model 60811C; Cardioblate Surgical Ablation Generator, Model 60880, Medtronic Vascular (2002) Summary page 1.
- K043579: Atricure Bipolar System, AtriCure, Inc. (2007) Summary page 2.

## Most influential descendants
- K093203: Cardioblate Bipolar Radiofrequency Surgical Ablation System, Models 60831, 60832, 60841 (2010), 3 descendants of its own
- K182610: Valleylab FT10 Electrosurgical Platform, Cardioblate BP2 Surgical Ablation Device, Cardioblate LP Surgical Ablation Device (2018), 2 descendants of its own
- K121767: Cardioblate Gemini Surgical Ablation Device (2012), 2 descendants of its own
- K200514: Cardioblate Gemini-s Surgical Ablation Device (2020), 1 descendant of its own
- K191601: Valleylab FT10 Electrosurgical Platform (2019), 1 descendant of its own

## Indications for use
The Medtronic Cardioblate® System is intended to ablate cardiac tissue during general surgery using radiofrequency energy.

Source page: https://510kreport.com/device/K080509
Methodology: https://510kreport.com/methodology